US Patent

US10835574 — Modulators of complement activity

Formulation · Assigned to Ra Pharmaceuticals Inc · Expires 2035-06-12 · 9y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects polypeptide modulators of complement activity, including cyclic polypeptide modulators, as therapeutics.

USPTO Abstract

The present invention relates to polypeptide modulators of complement activity, including cyclic polypeptide modulators. Included are methods of utilizing such modulators as therapeutics.

Drugs covered by this patent

Patent Metadata

Patent number
US10835574
Jurisdiction
US
Classification
Formulation
Expires
2035-06-12
Drug substance claim
No
Drug product claim
Yes
Assignee
Ra Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.